Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 18, 2023 08:00 ET | Source: HTG Molecular Diagnostics, Inc.

HTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International Convention

TUCSON, Ariz., May 18, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today announced that its...
May 16, 2023 08:47 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Highlights the Advantages of Its Drug Discovery Engine

TUCSON, Ariz., May 16, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported achievement of...
May 10, 2023 17:51 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights

TUCSON, Ariz., May 10, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported financial results...
April 25, 2023 08:00 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Provides Update on Drug Discovery Partnering Initiative

TUCSON, Ariz., April 25, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today provided an update on...
April 18, 2023 08:00 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Announces Key First Quarter Milestone Achievements for Drug Discovery

TUCSON, Ariz., April 18, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today announced the...
April 06, 2023 08:00 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Technology Featured in Numerous Scientific Posters at the AACR Annual Meeting April 16-19

TUCSON, Ariz., April 06, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today announced there will be...
January 09, 2023 08:33 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Provides a Year-End Update on its Drug Discovery Business and Attends LifeSci Partners 2023 Corporate Access Event

TUCSON, Ariz., Jan. 09, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
January 06, 2023 08:00 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Announces Certain Preliminary 2022 Unaudited Financial Results

Preliminary full year 2022 unaudited revenue of $6.4 million Cash and cash equivalents of $12.2 million as of December 31, 2022 TUCSON, Ariz., Jan. 06, 2023 (GLOBE NEWSWIRE) -- HTG Molecular...
December 28, 2022 08:00 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics Provides Highlights of its Second Event in Drug Discovery KOL Webcast Series

TUCSON, Ariz., Dec. 28, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
December 23, 2022 16:05 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics Announces Closing of a $10 Million Public Offering

TUCSON, Ariz., Dec. 23, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...